Resultat 1 - 3 av 3
Flerie-bolag slutför del av studie – tar in pengar
Investmentbolaget Flerie, med fokus på bioteknik- och läkemedelsinvesteringar, meddelar att portföljbolaget Anacardio har slutfört del A av fas 1b/2a-studien Goal-HF1 där peptidhormonet ghrelin utvärderades hos patienter med hjärtsvikt. Det framgår av ettSammanhang: ...Investmentbolaget Flerie, med fokus på bioteknik- och läkemedelsinvesteringar, meddelar att portföljbolaget Anacardio har slutfört del A av fas 1b/2a-studien Goal-HF1 där peptidhormonet ghrelin utvärderades hos patienter med hjärtsvikt. Det framgår av ett pressmeddelande....
Advania acquires UK based IT solution specialist CCS Media to further accelerate growth
Advania, a portfolio company of Goldman Sachs Alternatives and one of the largest providers of IT services in Northern Europe, has announced the acquisition of CCS Media, one of the largest independent IT solutions providers in the United Kingdom. This acquisitionSammanhang: ...This transaction represents a key milestone in Advania’s broader goal of becoming the leading IT services provider in Northern Europe and will further accelerate the growth of the group....
Bookdialysis.com enters strategic partnership with Uzbekistan Kidney Patient Association enabling CKD patients to resume travelling
Bookdialysis.com, the leading online booking engine for holiday dialysis patients, is delighted to announce that it has entered into a strategic partnership with the Uzbekistan Kidney Patient Association (KPA), with the goal to continue supporting ChronicSammanhang: ...Bookdialysis.com, the leading online booking engine for holiday dialysis patients, is delighted to announce that it has entered into a strategic partnership with the Uzbekistan Kidney Patient Association (KPA), with the goal to continue supporting Chronic Kidney Disease (CKD) patients, to feel free to explore new worlds....
Omnämnda personer: Uzbekistan Kidney, with Uzbekistan.